NHS England has awarded a new contract to US data analytics company Palantir to transition existing NHS projects into a new federated data platform (FDP), prompting pushback from organisations ...
NHS England has awarded US IT group Palantir the contract to create a new federated data platform (FDP) designed to bring together existing NHS data into a single framework, reigniting debate ...
Sometimes a new technology comes along that immediately shakes the world. The release this week of the new Chinese artificial ...
Edward Sheldon is looking to buy more artificial intelligence stocks for his portfolio in 2025. And these two tech innovators ...
Palantir’s artificial-intelligence-powered platform has helped drive growth at the software company in recent times. The stock advanced more than 300% last year for the best performance on the S ...
Palantir would need to grow into a $6.7 trillion market cap to turn a $25,000 investment into $1 million. This would be its valuation if it grew to 40 times its size today.
On Feb. 3, Palantir will be reporting fourth-quarter earnings -- offering us a recent view of how these growth drivers are progressing. There's reason to be optimistic about what the company may say.
In 2024, Palantir Technologies (NASDAQ: PLTR) proved that it's one of today's key technology leaders. The software company reported record profit, saw revenue climb quarter after quarter in the ...
Palantir Technologies (PLTR) has been grabbing today’s headlines for good reason. The big data analytical firm is a key player in the government and commercial sectors, and its ability to ...
DeepSeek’s cost-efficient AI disrupts the market but benefits Palantir, as lower AI costs accelerate adoption, increasing demand for Palantir’s secure, enterprise-grade AI integration.
That forecast implies 14% upside from its current share price of $79. Ives thinks Palantir could be the next Oracle, a software company worth $515 billion. That comparison implies 185% upside from ...
Dan Ives at Wedbush Securities recently raised his target price on Palantir, and he sees substantial upside over the next three to five years. Forrester Research analysts have ranked Palantir's ...